Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span

Antonello Lorenzini, Adam B. Salmon, Chad Lerner, Claudio Torres, Yuji Ikeno, Susan Motch, Roger McCarter, Christian Sell

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Reduced signaling through the IGF type 1 (IGF-1) receptor increases life span in multiple invertebrate organisms. Studies on mammalian longevity suggest that reducing levels of IGF-1 may also increase life span. However, the data are conflicting and complicated by the physiology of the mammalian neuroendocrine system. We have performed life-span analysis on mice homozygous for an insertion in the Igf1 gene. These mice produce reduced levels of IGF-1 and display a phenotype consistent with a significant decrease in IGF-1. Life-span analysis was carried out at three independent locations. Although the life-span data varied between sites, the maximum life span of the IGF-1-deficient mice was significantly increased and age-specific mortality rates were reduced in the IGF-1-deficient mice; however, mean life span did not differ except at one site, where mean life span was increased in female IGF-1-deficient animals. Early life mortality was noted in one cohort of IGF-1-deficient mice. The results are consistent with a significant role for IGF-1 in the modulation of life span but contrast with the published life-span data for the hypopituitary Ames and Snell dwarf mice and growth hormone receptor null mice, indicating that a reduction in IGF-1 alone is insufficient to increase both mean and maximal life span in mice.

Original languageEnglish (US)
Pages (from-to)410-419
Number of pages10
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume69
Issue number4
DOIs
StatePublished - Jan 1 2014

Fingerprint

Somatomedins
Insulin-Like Growth Factor I
Somatotropin Receptors
IGF Type 1 Receptor
Neurosecretory Systems
Mortality
Invertebrates
Phenotype

All Science Journal Classification (ASJC) codes

  • Aging
  • Geriatrics and Gerontology

Cite this

Lorenzini, Antonello ; Salmon, Adam B. ; Lerner, Chad ; Torres, Claudio ; Ikeno, Yuji ; Motch, Susan ; McCarter, Roger ; Sell, Christian. / Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span. In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2014 ; Vol. 69, No. 4. pp. 410-419.
@article{2e1ad1de0a1a4f6481e08956ee76ce36,
title = "Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span",
abstract = "Reduced signaling through the IGF type 1 (IGF-1) receptor increases life span in multiple invertebrate organisms. Studies on mammalian longevity suggest that reducing levels of IGF-1 may also increase life span. However, the data are conflicting and complicated by the physiology of the mammalian neuroendocrine system. We have performed life-span analysis on mice homozygous for an insertion in the Igf1 gene. These mice produce reduced levels of IGF-1 and display a phenotype consistent with a significant decrease in IGF-1. Life-span analysis was carried out at three independent locations. Although the life-span data varied between sites, the maximum life span of the IGF-1-deficient mice was significantly increased and age-specific mortality rates were reduced in the IGF-1-deficient mice; however, mean life span did not differ except at one site, where mean life span was increased in female IGF-1-deficient animals. Early life mortality was noted in one cohort of IGF-1-deficient mice. The results are consistent with a significant role for IGF-1 in the modulation of life span but contrast with the published life-span data for the hypopituitary Ames and Snell dwarf mice and growth hormone receptor null mice, indicating that a reduction in IGF-1 alone is insufficient to increase both mean and maximal life span in mice.",
author = "Antonello Lorenzini and Salmon, {Adam B.} and Chad Lerner and Claudio Torres and Yuji Ikeno and Susan Motch and Roger McCarter and Christian Sell",
year = "2014",
month = "1",
day = "1",
doi = "10.1093/gerona/glt108",
language = "English (US)",
volume = "69",
pages = "410--419",
journal = "Journals of Gerontology - Series A Biological Sciences and Medical Sciences",
issn = "1079-5006",
publisher = "Oxford University Press",
number = "4",

}

Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span. / Lorenzini, Antonello; Salmon, Adam B.; Lerner, Chad; Torres, Claudio; Ikeno, Yuji; Motch, Susan; McCarter, Roger; Sell, Christian.

In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 69, No. 4, 01.01.2014, p. 410-419.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span

AU - Lorenzini, Antonello

AU - Salmon, Adam B.

AU - Lerner, Chad

AU - Torres, Claudio

AU - Ikeno, Yuji

AU - Motch, Susan

AU - McCarter, Roger

AU - Sell, Christian

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Reduced signaling through the IGF type 1 (IGF-1) receptor increases life span in multiple invertebrate organisms. Studies on mammalian longevity suggest that reducing levels of IGF-1 may also increase life span. However, the data are conflicting and complicated by the physiology of the mammalian neuroendocrine system. We have performed life-span analysis on mice homozygous for an insertion in the Igf1 gene. These mice produce reduced levels of IGF-1 and display a phenotype consistent with a significant decrease in IGF-1. Life-span analysis was carried out at three independent locations. Although the life-span data varied between sites, the maximum life span of the IGF-1-deficient mice was significantly increased and age-specific mortality rates were reduced in the IGF-1-deficient mice; however, mean life span did not differ except at one site, where mean life span was increased in female IGF-1-deficient animals. Early life mortality was noted in one cohort of IGF-1-deficient mice. The results are consistent with a significant role for IGF-1 in the modulation of life span but contrast with the published life-span data for the hypopituitary Ames and Snell dwarf mice and growth hormone receptor null mice, indicating that a reduction in IGF-1 alone is insufficient to increase both mean and maximal life span in mice.

AB - Reduced signaling through the IGF type 1 (IGF-1) receptor increases life span in multiple invertebrate organisms. Studies on mammalian longevity suggest that reducing levels of IGF-1 may also increase life span. However, the data are conflicting and complicated by the physiology of the mammalian neuroendocrine system. We have performed life-span analysis on mice homozygous for an insertion in the Igf1 gene. These mice produce reduced levels of IGF-1 and display a phenotype consistent with a significant decrease in IGF-1. Life-span analysis was carried out at three independent locations. Although the life-span data varied between sites, the maximum life span of the IGF-1-deficient mice was significantly increased and age-specific mortality rates were reduced in the IGF-1-deficient mice; however, mean life span did not differ except at one site, where mean life span was increased in female IGF-1-deficient animals. Early life mortality was noted in one cohort of IGF-1-deficient mice. The results are consistent with a significant role for IGF-1 in the modulation of life span but contrast with the published life-span data for the hypopituitary Ames and Snell dwarf mice and growth hormone receptor null mice, indicating that a reduction in IGF-1 alone is insufficient to increase both mean and maximal life span in mice.

UR - http://www.scopus.com/inward/record.url?scp=84898976404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898976404&partnerID=8YFLogxK

U2 - 10.1093/gerona/glt108

DO - 10.1093/gerona/glt108

M3 - Article

C2 - 23873963

AN - SCOPUS:84898976404

VL - 69

SP - 410

EP - 419

JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

SN - 1079-5006

IS - 4

ER -